Home

Sofinnova Management VII, L.L.C.

CIK 1421501 · last filed 2015-05-08

Sofinnova Management VII, L.L.C. is a corporate insider who has filed 6 SEC Form 4 insider transactions across 4 companies since 2011. The most recent filing, for HPTX, was dated May 8, 2015. Across all open-market trades the lifetime net is −$156.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.77M

Companies

4

Total Filings

6

Lifetime Open-Market Net

-$156.82M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HYPERION THERAPEUTICS INC (HPTX) Delisted 10%+ Owner 1,592,185 — — $28.15M 2 2015-05-08
AERIE PHARMACEUTICALS INC (AERI) Delisted 10%+ Owner 1,566,657 $15.25 $23.89M -$121.04M 1 2014-07-11
Durata Therapeutics, Inc. (DRTX) Delisted 10%+ Owner 2,277,580 — — $26.47M 1 2012-07-25
AMRN 10%+ Owner 425,669 $13.55 $5.77M -$90.40M 2 2011-03-31

Recent Filings

6 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2015-05-08 HYPERION THERAPEUTICS INC (HPTX) Delisted U −7,757,896 -$356.86M EDGAR
2014-07-11 AERIE PHARMACEUTICALS INC (AERI) Delisted Sell (S) −5,040,110 -$121.04M EDGAR
2012-08-02 HYPERION THERAPEUTICS INC (HPTX) Delisted Mixed +14,716,435 $28.15M EDGAR
2012-07-25 Durata Therapeutics, Inc. (DRTX) Delisted Mixed +11,356,650 $26.47M EDGAR
2011-03-31 AMRN Sell (S) −2,124,500 -$15.40M EDGAR
2011-03-14 AMRN Sell (S) −10,000,000 -$75.00M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.